Top 10 Stocks Under $230
Discover investment opportunities in Top 10 Stocks Under $230 using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $230 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $230 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $230 using our Smart AI Filter.
6 stocks found for "Top 10 Stocks Under $230"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.56 Risk measure | ±73.5% Price volatility | -25.1 Valuation | 0.00% Annual yield | |||
1.20 Risk measure | ±47.2% Price volatility | 62.2 Valuation | 0.31% Annual yield | |||
0.54 Risk measure | ±32.2% Price volatility | 27.1 Valuation | 0.46% Annual yield | |||
1.41 Risk measure | ±45.9% Price volatility | 11.0 Valuation | 1.84% Annual yield | |||
0.83 Risk measure | ±32.5% Price volatility | 20.0 Valuation | 0.47% Annual yield | |||
0.79 Risk measure | ±45.4% Price volatility | 15.6 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How does Apple's (AAPL) current valuation impact its attractiveness to investors?
A: Apple's valuation reflects its position as a global tech leader with strong revenue streams from products and services. The stock's P/E ratio and growth metrics should be analyzed in relation to industry peers to assess its investment appeal.
Q: What factors contribute to Alphabet's (GOOGL) growth potential?
A: Alphabet benefits from dominant market positions in online advertising, AI, and cloud computing. Investors may consider its innovation pipeline and resilience to advertising market fluctuations as key growth drivers.
Q: How might geopolitical tensions affect Alibaba's (BABA) performance?
A: Geopolitical tensions can impact Alibaba's operations, particularly regarding US-China trade relations and regulatory challenges. These risks may influence investor sentiment and stock performance.
Q: What are the prospects for Cameco (CCJ) in the uranium market?
A: Cameco is a major player in uranium production, potentially benefiting from rising global demand for nuclear energy. However, price volatility and regulatory changes could pose risks to its stock.
Q: Why is Unity Software (U) considered a growth stock in the tech industry?
A: Unity's growth prospects are fueled by its leading position in real-time 3D content creation across gaming and non-gaming industries. Its expanding market applications support its classification as a growth stock.
Q: What should investors know about Digi International's (DGII) financial health?
A: Digi International focuses on IoT connectivity solutions. Investors should evaluate its balance sheet strength, revenue growth, and potential debt levels for a comprehensive view of its financial health.
Starbucks plans to tap into consumers' protein obsession by launching protein-packed cold foam and lattes starting Sept. 29. From 'gym bros' to users of GLP-1 drugs like Ozempic, many Americans are trying to consume more protein, with the goal of building or maintaining their muscle mass and feeling more satiated after meals.
Read moreWall Street is flexing harder than ever in 2025, and it's not through flashy M&A or moonshot R&D—it's with cash. U.S. corporate titans, led by Apple Inc AAPL, Alphabet Inc GOOGL GOOG and Nvidia Corp NVDA, have unveiled nearly $430 billion in stock buybacks this year, the biggest show of financial firepower yet.
Read more